Literature DB >> 8987409

Falciparum malaria with acute liver failure.

A Srivastava1, A Khanduri, S Lakhtakia, R Pandey, G Choudhuri.   

Abstract

INTRODUCTION: Falciparum malaria occasionally presents with encephalopathy, jaundice and fever mimicking fulminant hepatic failure. PATIENTS: We recently managed seven cases (mean age 34 years, range 20-45; all men) of acute falciparum malaria presenting with a short history [mean duration 8.1 (4-15) days] of fever, jaundice, altered sensorium and oliguria. Only one patient had splenomegaly. Investigations revealed jaundice (bilirubin 1.9-30.7 mg/dl), moderate to severe anaemia (Hb 4-8 gm/dl), increased liver enzymes (2-4 times normal) and azotaemia (serum creatinine 1.6-7.4 mg/dl). Coagulation parameters were deranged in 3 with clinical bleeding in two cases. One patient without a past history of diabetes had increased blood glucose values with ketonuria. HBsAg was negative in all cases. Patients received supportive therapy along with intravenous quinine. Peritoneal dialysis was done in one patient. Three patients showed rapid recovery and four succumbed to the disease. Post-mortem liver biopsy showed Kupffer cell hyperplasia, pigment deposition, foci of steatosis and necrosis along with submassive necrosis in one case.
CONCLUSIONS: In areas endemic for malaria, awareness of this entity is a must. In a patient with jaundice and altered sensorium, disproportionate anaemia, azotaemia and only mild elevation of liver enzymes should help differentiate these patients from cases of fulminant hepatic failure. The diagnosis can be confirmed by peripheral blood examination. Early institution of specific therapy may be the only life saving measure in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987409

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  7 in total

1.  Review.

Authors:  Dhanpat Kumar Kochar; Parmendra Sirohi; Kochar Abhishek
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

2.  Acute Hepatitis in Malaria.

Authors:  Hatem Shoukier; Sandeep Dham; Nora V Bergasa; Dhanpat Kumar Kochar; Parmendra Sirohi; Kochar Abhishek
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

3.  Supplementation with Abscisic Acid Reduces Malaria Disease Severity and Parasite Transmission.

Authors:  Elizabeth K K Glennon; L Garry Adams; Derrick R Hicks; Katayoon Dehesh; Shirley Luckhart
Journal:  Am J Trop Med Hyg       Date:  2016-03-21       Impact factor: 2.345

4.  Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKA.

Authors:  Yuri Chaves Martins; Mary Jane Smith; Marcelo Pelajo-Machado; Guilherme Loureiro Werneck; Henrique Leonel Lenzi; Claudio Tadeu Daniel-Ribeiro; Leonardo José de Moura Carvalho
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

5.  Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression.

Authors:  Parnpen Viriyavejakul; Vasant Khachonsaksumet; Chuchard Punsawad
Journal:  Malar J       Date:  2014-03-17       Impact factor: 2.979

6.  A Novel Model of Asymptomatic Plasmodium Parasitemia That Recapitulates Elements of the Human Immune Response to Chronic Infection.

Authors:  Mary F Fontana; Alyssa Baccarella; Joshua F Craft; Michelle J Boyle; Tara I McIntyre; Matthew D Wood; Kurt S Thorn; Chioma Anidi; Aqieda Bayat; Me Ree Chung; Rebecca Hamburger; Chris Y Kim; Emily Pearman; Jennifer Pham; Jia J Tang; Louis Boon; Moses R Kamya; Grant Dorsey; Margaret E Feeney; Charles C Kim
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

7.  Liver Injury in Uncomplicated Malaria is an Overlooked Phenomenon: An Observational Study.

Authors:  Isaie J Reuling; Gerdie M de Jong; Xi Zen Yap; Muhammad Asghar; Jona Walk; Lisanne A van de Schans; Rob Koelewijn; Anna Färnert; Quirijn de Mast; Andre J van der Ven; Teun Bousema; Jaap J van Hellemond; Perry J J van Genderen; Robert W Sauerwein
Journal:  EBioMedicine       Date:  2018-09-19       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.